Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-25 @ 2:18 PM
NCT ID:
NCT02159066
Population Description:
Analysis population: participants who were treated with at least 1 dose (partial or full) of encorafenib or binimetinib in Part I and at least 1 dose of encorafenib or binimetinib or the assigned third agent following the assignment of the triple combination treatment in Part II. Parts I and II participants are not exclusive. To avoid risk of identification of participant, baseline measure data is not disclosed for reporting arm including Infigratinib and reported under category- Not Disclosed.
Study:
NCT02159066
Study Brief:
Results Section:
NCT02159066